Developer docs
API playgroundTry for free, no card

Search company profiles

MIT linQ

Full company profile

uuid002shiu

Namestring
MIT linQ
Legal namestring
MIT linQ
Websiteurl
linq.mit.edu
Company typeenum
Private
Founded yearint
2016
Descriptiontext

MIT linQ is an international innovation program based at the Massachusetts Institute of Technology in Cambridge, MA, founded in 2016 to accelerate and heighten the impact of biomedical research on health and society. The organization operates four cohort-based programs — Catalyst (project nucleation), IMPACT (career preparation for post-doctoral and advanced pre-doctoral trainees), IDEA² (commercialization mentorship for project teams), and Rising Stars (career development for women and underrepresented minorities) — all guided by the proprietary "linQ innovation method," a needs-focused framework that integrates medical, technological, and business perspectives to drive research from unmet-need definition toward real-world implementation.

Underlying the programs is a multidisciplinary community of faculty, fellows, and expert advisors from engineering, science, medicine, and business, drawn from MIT and partner institutions in the Boston area and internationally. Spinout technologies emerge from the cohorts, including PointCheck by Leuko Labs (a noninvasive white blood cell monitoring device for chemotherapy patients, originated in Catalyst). MIT linQ collaborates structurally with several MIT units — the Office of Innovation, the Deshpande Center for Technological Innovation, the Industrial Liaison Program, the Technology Licensing Office, and MIT Hacking Medicine — positioning itself as a connective layer across MIT's translational stack.

The business model is non-commercial: MIT linQ is funded through a combination of Champion organization sponsorships (e.g., GE Health, Cantabria Labs, PDS, Veterans Affairs, VHA Innovation Ecosystem, University of Debrecen), public agency grants (NIH, EIT Health), and MIT institutional support. Go-to-market is community-led, relying on MIT's brand, cohort recruitment, the linQ innovation method's reputation, and showcase placements such as the permanent "Essential MIT" exhibit at the MIT Museum (October 2022). Operations are run by a small core team (1–10 employees), led by Director Martha Gray, PhD, with program leadership distributed across Catalyst, IMPACT, IDEA², and Rising Stars leads.

Short descriptiontext

MIT linQ is an MIT-based academic innovation program that runs four cohort-based programs (Catalyst, IMPACT, IDEA², Rising Stars) using a proprietary needs-focused method to help postdoctoral researchers and students translate biomedical research into real-world health technologies, supported by grants and corporate Champions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical innovation programs, health technology training, innovation fellowships, research translation methods, academic consortium programs
Industry1 code
1AI & Machine Learning (Foundations & Applied)
CodeEDAMACAGPrimaryYes
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Consulting Services8742
Product category
Biomedical Innovation Training Programs
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Program sponsorship and grants
TypeLicensing Royalties
Description

MIT linQ receives support through initiative sponsors, champion organizations that provide financial and intellectual support, and public agencies and foundations that fund program editions. This is a research/educational organization rather than a commercial entity.

linq.mit.edu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Catalyst
Description

Program for nucleating high potential new projects without constraint of a single lab or institution. Cohorts of Catalyst Fellows identify and define unmet medical needs and develop new technologies.

linq.mit.edu
+3 more records
Core offering1 text field

MIT linQ operates a structured biomedical technology innovation program portfolio built around the proprietary linQ innovation method. It runs four cohort-based programs—Catalyst, IMPACT, IDEA², and Rising Stars—that train researchers and clinicians to identify unmet medical needs, form multidisciplinary teams, develop commercialization strategies, and accelerate research-driven health technology projects from discovery to venture.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Innovation milestone achievement rates higher than MIT benchmark
Product overview1 text field

MIT linQ is an innovation ecosystem comprising four interconnected programs designed to accelerate research-driven health technology development. The core programs include Catalyst (for nucleating high-potential biomedical technology projects), IMPACT (career preparation for post-doctoral and pre-doctoral trainees), IDEA² (mentorship and commercialization strategy for project teams), and Rising Stars (career development for women and underrepresented minorities). These programs are guided by the linQ innovation method and are designed to work together to help participants progress from identifying unmet medical needs through to launching new ventures. The portfolio also includes spinout technologies such as PointCheck by Leuko Labs, a noninvasive white blood cell monitoring device developed through the Catalyst program.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeOthers
Description

Champions organization that provides financial and intellectual support to specific editions of linQ programs. Selected individuals from Champion organizations may meet with Fellows and project teams, offer comments and subject matter expertise on innovation priorities, and observe and learn about the program method.

Strategic tierCoreTypeOthers
Description

Champion organization providing financial and intellectual support to linQ programs. Offers subject matter expertise on innovation priorities and participates in program activities.

Strategic tierCoreTypeOthers
Description

Champion organization providing financial and intellectual support to specific editions of linQ programs.

Strategic tierCoreTypeOthers
Description

Champion organization providing financial and intellectual support to linQ programs. VA Innovation Ecosystem also partners with linQ.

Strategic tierCoreTypeOthers
Description

Champion organization providing financial and intellectual support to linQ programs for healthcare innovation.

Strategic tierCoreTypeOthers
Description

Champion organization providing financial and intellectual support to linQ programs, representing international academic collaboration.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

European public agency and foundation that has funded program editions, promoting new paradigms for research and innovation in health technology across Europe.

8MIT Office of Innovation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Internal MIT unit that is part of linQ's network, collaborating on innovation initiatives across the MIT ecosystem.

linq.mit.edu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MIT center that is part of linQ's network, supporting technological innovation at MIT.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MIT program that is part of linQ's network, facilitating industry connections and partnerships.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MIT office that manages technology commercialization and is part of linQ's innovation ecosystem.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MIT initiative focused on healthcare hackathons and innovation that is part of linQ's broader innovation community.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Seed-stage program for science-based startups with biomedical streams; comparable objective of turning academic research into fundable ventures, though structured as an objectives-based mentoring program.

TypeRegional player
Description

Imperial College London's health innovation institute that runs training and fellowship programs for biomedical innovators; similar mission to linQ but UK-based with different funder mix.

TypeEmerging player
Description

Biotech-focused accelerator that takes equity in biology startups; overlaps with linQ's venture-creation mission but operates as a for-profit accelerator rather than an academic program.

TypeDirect peer
Description

European public-private partnership that funds biomedical innovation programs and is itself a Champion/funder of linQ; directly comparable as a multi-program biomedical innovation training and acceleration ecosystem.

TypeDirect peer
Description

Stanford's flagship biomedical innovation fellowship program that trains multidisciplinary teams to identify unmet clinical needs and develop new health technologies — a near-direct analog to MIT linQ's Catalyst program in mission and structure.

TypeBroad incumbent
Description

MIT's central entrepreneurship hub offering mentorship, programs, and funding to MIT-affiliated founders; comparable as an MIT-anchored entrepreneurship training organization but broader than biomedical-specific.

TypeDirect peer
Description

St. Louis-based nonprofit that creates and funds early-stage life sciences companies, providing laboratory facilities, mentorship, and capital — comparable to linQ's role as a non-commercial biomedical venture-creation intermediary.

TypeDirect peer
Description

MIT initiative that organizes healthcare hackathons and innovation events; explicitly listed as part of linQ's network and addresses the same healthcare innovation training mission through a different cohort format.

TypeBroad incumbent
Description

MIT center that funds and mentors faculty-led technology innovation projects across domains, including biomedical; overlaps with linQ's IDEA² mission but operates at faculty-project rather than postdoc/graduate cohort level.

TypeDirect peer
Description

UCSF-affiliated health technology innovation platform that supports founders, clinicians, and investors in building medical device and digital health ventures; analogous to linQ's Catalyst/IDEA² functions in a different academic ecosystem.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MIT linQ

Biomedical Innovation Training Programslinq.mit.edu

MIT linQ is an MIT-based academic innovation program that runs four cohort-based programs (Catalyst, IMPACT, IDEA², Rising Stars) using a proprietary needs-focused method to help postdoctoral researchers and students translate biomedical research into real-world health technologies, supported by grants and corporate Champions.

What MIT linQ does

MIT linQ is an international innovation program based at the Massachusetts Institute of Technology in Cambridge, MA, founded in 2016 to accelerate and heighten the impact of biomedical research on health and society. The organization operates four cohort-based programs — Catalyst (project nucleation), IMPACT (career preparation for post-doctoral and advanced pre-doctoral trainees), IDEA² (commercialization mentorship for project teams), and Rising Stars (career development for women and underrepresented minorities) — all guided by the proprietary "linQ innovation method," a needs-focused framework that integrates medical, technological, and business perspectives to drive research from unmet-need definition toward real-world implementation.

Underlying the programs is a multidisciplinary community of faculty, fellows, and expert advisors from engineering, science, medicine, and business, drawn from MIT and partner institutions in the Boston area and internationally. Spinout technologies emerge from the cohorts, including PointCheck by Leuko Labs (a noninvasive white blood cell monitoring device for chemotherapy patients, originated in Catalyst). MIT linQ collaborates structurally with several MIT units — the Office of Innovation, the Deshpande Center for Technological Innovation, the Industrial Liaison Program, the Technology Licensing Office, and MIT Hacking Medicine — positioning itself as a connective layer across MIT's translational stack.

The business model is non-commercial: MIT linQ is funded through a combination of Champion organization sponsorships (e.g., GE Health, Cantabria Labs, PDS, Veterans Affairs, VHA Innovation Ecosystem, University of Debrecen), public agency grants (NIH, EIT Health), and MIT institutional support. Go-to-market is community-led, relying on MIT's brand, cohort recruitment, the linQ innovation method's reputation, and showcase placements such as the permanent "Essential MIT" exhibit at the MIT Museum (October 2022). Operations are run by a small core team (1–10 employees), led by Director Martha Gray, PhD, with program leadership distributed across Catalyst, IMPACT, IDEA², and Rising Stars leads.

MIT linQ firmographics

Firmographics
Name
MIT linQ
Legal name
MIT linQ
Website
https://linq.mit.edu
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
MIT linQ is an MIT-based academic innovation program that runs four cohort-based programs (Catalyst, IMPACT, IDEA², Rising Stars) using a proprietary needs-focused method to help postdoctoral researchers and students translate biomedical research into real-world health technologies, supported by grants and corporate Champions.
Ownership category
akta.pro rank

MIT linQ industry classification

Industry
Product category
Biomedical Innovation Training Programs
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
akta.pro primary industry
AI & Machine Learning (Foundations & Applied) (EDAMACAG)

Keywords

  • Biomedical innovation programs
  • Health technology training
  • Innovation fellowships
  • Research translation methods
  • Academic consortium programs

Where MIT linQ is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MIT linQ business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Program sponsorship and grants: MIT linQ receives support through initiative sponsors, champion organizations that provide financial and intellectual support, and public agencies and foundations that fund program editions. This is a research/educational organization rather than a commercial entity.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

MIT linQ product offering

Product offering

Core offering

MIT linQ operates a structured biomedical technology innovation program portfolio built around the proprietary linQ innovation method. It runs four cohort-based programs—Catalyst, IMPACT, IDEA², and Rising Stars—that train researchers and clinicians to identify unmet medical needs, form multidisciplinary teams, develop commercialization strategies, and accelerate research-driven health technology projects from discovery to venture.

Product overview

MIT linQ is an innovation ecosystem comprising four interconnected programs designed to accelerate research-driven health technology development. The core programs include Catalyst (for nucleating high-potential biomedical technology projects), IMPACT (career preparation for post-doctoral and pre-doctoral trainees), IDEA² (mentorship and commercialization strategy for project teams), and Rising Stars (career development for women and underrepresented minorities). These programs are guided by the linQ innovation method and are designed to work together to help participants progress from identifying unmet medical needs through to launching new ventures. The portfolio also includes spinout technologies such as PointCheck by Leuko Labs, a noninvasive white blood cell monitoring device developed through the Catalyst program.

Differentiator

Problem solved

Functional benefit

Brands

  • Catalyst: Program for nucleating high potential new projects without constraint of a single lab or institution. Cohorts of Catalyst Fellows identify and define unmet medical needs and develop new technologies.
  • IMPACT
  • IDEA²
  • Rising Stars

Quantifiable outcome

  • Innovation milestone achievement rates higher than MIT benchmark

Companies that use MIT linQ

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles2 records

MIT linQ technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

MIT linQ partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and major.

  • Cantabria LabscoreOthersChampions organization that provides financial and intellectual support to specific editions of linQ programs. Selected individuals from Champion organizations may meet with Fellows and project teams, offer comments and subject matter expertise on innovation priorities, and observe and learn about the program method.
  • GE HealthcoreOthersChampion organization providing financial and intellectual support to linQ programs. Offers subject matter expertise on innovation priorities and participates in program activities.
  • PDScoreOthersChampion organization providing financial and intellectual support to specific editions of linQ programs.
  • Veterans Affairs (VA)coreOthersChampion organization providing financial and intellectual support to linQ programs. VA Innovation Ecosystem also partners with linQ.
  • VHA Innovation EcosystemcoreOthersChampion organization providing financial and intellectual support to linQ programs for healthcare innovation.
  • University of DebrecencoreOthersChampion organization providing financial and intellectual support to linQ programs, representing international academic collaboration.
  • EIT HealthmajorStrategic or Co-development PartnerEuropean public agency and foundation that has funded program editions, promoting new paradigms for research and innovation in health technology across Europe.
  • MIT Office of InnovationcoreStrategic or Co-development PartnerInternal MIT unit that is part of linQ's network, collaborating on innovation initiatives across the MIT ecosystem.
  • Deshpande Center for Technological InnovationcoreStrategic or Co-development PartnerMIT center that is part of linQ's network, supporting technological innovation at MIT.
  • MIT Industrial Liaison Program (ILP)coreStrategic or Co-development PartnerMIT program that is part of linQ's network, facilitating industry connections and partnerships.
  • MIT Technology Licensing Office (TLO)coreStrategic or Co-development PartnerMIT office that manages technology commercialization and is part of linQ's innovation ecosystem.
  • MIT Hacking MedicinecoreStrategic or Co-development PartnerMIT initiative focused on healthcare hackathons and innovation that is part of linQ's broader innovation community.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

MIT linQ competitors and assessment

Company assessment

Emerging players

  • Creative Destruction Lab: Seed-stage program for science-based startups with biomedical streams; comparable objective of turning academic research into fundable ventures, though structured as an objectives-based mentoring program.
  • IndieBio: Biotech-focused accelerator that takes equity in biology startups; overlaps with linQ's venture-creation mission but operates as a for-profit accelerator rather than an academic program.

Regional players

Direct peers

  • EIT Health: European public-private partnership that funds biomedical innovation programs and is itself a Champion/funder of linQ; directly comparable as a multi-program biomedical innovation training and acceleration ecosystem.
  • Stanford Byers Center for Biodesign: Stanford's flagship biomedical innovation fellowship program that trains multidisciplinary teams to identify unmet clinical needs and develop new health technologies — a near-direct analog to MIT linQ's Catalyst program in mission and structure.
  • BioGenerator: St. Louis-based nonprofit that creates and funds early-stage life sciences companies, providing laboratory facilities, mentorship, and capital — comparable to linQ's role as a non-commercial biomedical venture-creation intermediary.
  • MIT Hacking Medicine: MIT initiative that organizes healthcare hackathons and innovation events; explicitly listed as part of linQ's network and addresses the same healthcare innovation training mission through a different cohort format.
  • UCSF Rosenman Institute: UCSF-affiliated health technology innovation platform that supports founders, clinicians, and investors in building medical device and digital health ventures; analogous to linQ's Catalyst/IDEA² functions in a different academic ecosystem.

Broad incumbents

  • MIT Martin Trust Center for MIT Entrepreneurship: MIT's central entrepreneurship hub offering mentorship, programs, and funding to MIT-affiliated founders; comparable as an MIT-anchored entrepreneurship training organization but broader than biomedical-specific.
  • MIT Deshpande Center for Technological Innovation: MIT center that funds and mentors faculty-led technology innovation projects across domains, including biomedical; overlaps with linQ's IDEA² mission but operates at faculty-project rather than postdoc/graduate cohort level.

Market position

Strengths4 records

Weaknesses3 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

MIT linQ social profiles

Digital presence

MIT linQ financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MIT linQ leadership team

Management profile

Number of profiles

Profiles5 records

MIT linQ funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MIT linQ M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MIT linQ

What does MIT linQ do?

MIT linQ operates a structured biomedical technology innovation program portfolio built around the proprietary linQ innovation method. It runs four cohort-based programs—Catalyst, IMPACT, IDEA², and Rising Stars—that train researchers and clinicians to identify unmet medical needs, form multidisciplinary teams, develop commercialization strategies, and accelerate research-driven health technology projects from discovery to venture.

Is MIT linQ a public or private company?

MIT linQ is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was MIT linQ founded?

MIT linQ was founded in 2016. It employs 1 to 10 people.

Where is MIT linQ based?

MIT linQ is headquartered in Cambridge, United States, in the North America region.

How does MIT linQ make money?

One revenue line is on record: program sponsorship and grants.

Who are MIT linQ's main competitors?

Emerging players on record are Creative Destruction Lab and IndieBio. Imperial College Institute of Global Health Innovation is listed as a regional player. Direct peers are EIT Health, Stanford Byers Center for Biodesign, BioGenerator, MIT Hacking Medicine and UCSF Rosenman Institute. Broad incumbents are MIT Martin Trust Center for MIT Entrepreneurship and MIT Deshpande Center for Technological Innovation.

Does MIT linQ have an API?

No public API is recorded for MIT linQ.

What industry is MIT linQ in?

MIT linQ's product category is Biomedical Innovation Training Programs. Its primary akta.pro industry code is EDAMACAG, AI & Machine Learning (Foundations & Applied). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales